The pharmaceutical industry shares concerns about the environmental impact of PFAS. However, PFAS is a broad non-specific term which does not inform whether a compound is harmful, and not all PFAS present the same risks to the environment or health. The potential impact of a Europe-wide ban on PFAS in pharmaceutical products, packaging and operations is significant. We need strategic planning and alternative approaches to avoid disruptions in patient care. Check our infographic and read more here.
